A new study reveals previously unknown risk factors associated with an eye condition that causes serious progressive nearsightedness at a relatively young age. The findings, made through the largest-ever clinical study of the condition called keratoconus, could help more people receive newer treatments that can slow the problem and protect their vision.
Winter in Ann Arbor pales in comparison with the cold, snowy darkness of Finland or Norway at this time of year. But the University of Michigan Life Sciences will try to melt some of the Nordic frost on Sunday, Jan. 24 with a concert featuring two Scandinavian composers.
early every girl and woman on Earth carries two X chromosomes in nearly every one of her cells – but one of them does (mostly) nothing. That’s because it’s been silenced, keeping most of its DNA locked up and unread like a book in a cage. Scientists thought they had figured out how cells do this, but a new piece of U-M research shows the answer isn’t quite that clear.
Although obesity rates were higher among African-American and Hispanic kids, the relationship disappeared when factoring in family income. Fewer resources like places to exercise and access to full service grocery stores appear to have a greater impact on the nation’s childhood obesity rate than race.
Just six months after opening up health insurance to more low-income people, states saw a huge drop in the amount of care their hospitals provided to uninsured patients, and a rise in care for people with coverage, a new study finds.
Researchers found that only 55 percent of colorectal cancer patients who were employed at the time of diagnosis retained their jobs after treatment. Patients who had paid sick leave were nearly twice as likely to retain their jobs as those without paid sick leave.
An international team of scientists, that includes researchers from the University of Michigan, has identified 16 new genetic variations for age-related macular degeneration (AMD). Their findings nearly double the number of regions, or loci, associated with the disease.
More than one in four doctors in the early stages of their careers has signs of depression, a comprehensive new study finds. And the grueling years of training for a medical career may deserve some of the blame.
Within weeks, flu will start spreading. Multiple national recommendations urge all healthcare workers to get the influenza vaccination, to reduce the chances they will pass the virus on to their patients. But a new study finds that more than half of hospitals still don’t require this.
Researchers at the University of Michigan have identified a potential new approach to fertility preservation for young cancer patients that addresses concerns about beginning cancer treatment immediately and the possibility of reintroducing cancer cells during the fertility preservation process.
When researchers looked at different areas within an individual rectal cancer sample, they found cases in which each area contained different genetic mutations. The findings could have significant implications for treatment recommendations.
This Thursday through Saturday, nearly 200 U-M Medical School students will hit the streets of Ann Arbor, and the halls of the U-M Health System’s hospitals and clinics, to collect money for a great cause.
If you think your life is stressful, try being a new doctor. Their first year especially is a time of stress, sleeplessness and self-doubt – and four times the usual rate of suicidal thoughts. But a new study shows that a free web-based tool to support their mental health may cut that rate in half.
Deep within your DNA, a tiny parasite lurks, waiting to pounce from its perch and land in the middle of an unsuspecting healthy gene. If it succeeds, it can make you sick. Like a jungle cat, this parasite sports a long tail. But until now no one has ever figured out what role that tail plays in this dangerous jumping.
ura Oncology Inc., a clinical stage biopharmaceutical company that develops therapies for cancer patients, is now trading on the NASDAQ after an initial public offering. The technology behind the company comes from researchers at the University of Michigan Medical School, and others.
Right now, in any American hospital, about half of the patients have a prescription for an acid-reducing drug to reduce heartburn or prevent bleeding in their stomach and gut. But that well-intentioned drug may actually boost their risk of dying during their hospital stay, a new study finds – by opening them up to infections that pose more risk than bleeding would.
When it comes to preventing stroke, millions of Americans with irregular heartbeats face a choice: Take one of the powerful but pricey new pills they see advertised on TV, or a much cheaper 60-year-old drug that can be a hassle to take, and doesn’t prevent stroke as well. It doesn’t seem like much of a contest -- until you do the math.
f you don’t have health insurance, or your insurance coverage still leaves you with big bills, hospitals are supposed to let you know if you qualify for free or reduced-price care, and to charge you fairly even if you don’t, if they want to keep their tax-free nonprofit status. But a new study finds many nonprofit hospitals have room to improve.
Anyone who takes medicine to get their blood sugar or blood pressure down – or both – knows their doctor prescribed it to help them. But what if stopping, or at least cutting back on, such drugs could help even more? Two new studies explore how often doctors use this option.
A new study from the University of Michigan Comprehensive Cancer Center reveals molecular changes within a tumor that are preventing immunotherapy drugs from killing off the cancer. It explains why not all patients respond to immunotherapy treatments.